PRA Health Sciences Company Profile (NASDAQ:PRAH)

Analyst Ratings

Consensus Ratings for PRA Health Sciences (NASDAQ:PRAH) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $47.44 (7.28% upside)

Analysts' Ratings History for PRA Health Sciences (NASDAQ:PRAH)
Show:
DateFirmActionRatingPrice TargetActions
6/20/2016First AnalysisInitiated CoverageEqual -> Equal Weight$47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2016Credit Suisse Group AGInitiated CoverageNeutral$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016KeyCorpUpgradeSector Weight -> Overweight$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Citigroup Inc.UpgradeNeutral -> Buy$51.00 -> $53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016SunTrust Banks Inc.UpgradeNeutral -> Buy$47.00 -> $51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Jefferies GroupBoost Price Target$49.50 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Avondale PartnersDowngradeMarket Perform -> Underperform$31.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015Robert W. BairdBoost Price TargetOutperform$47.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014Wells Fargo & Co.Initiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for PRA Health Sciences (NASDAQ:PRAH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/29/2016ListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2016Q116$0.53$0.55$372.21 million$372.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2016Q4$0.49$0.59$353.42 million$428.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2015Q3$0.45$0.52$346.05 million$345.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/27/2015Q215$0.40$0.47$336.74 million$336.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115$0.31$0.41$329.80 million$332.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2015Q414$0.30$0.35$323.50 million$370.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PRA Health Sciences (NASDAQ:PRAH)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.47$0.51$0.49
Q2 20162$0.56$0.59$0.58
Q3 20163$0.62$0.63$0.62
Q4 20162$0.63$0.69$0.66
(Data provided by Zacks Investment Research)

Dividends

Dividend History for PRA Health Sciences (NASDAQ:PRAH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for PRA Health Sciences (NASDAQ:PRAH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/6/2016Linda BaddourCFOSell92,308$46.70$4,310,783.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Pra Investors L.P. KkrMajor ShareholderSell4,907,692$46.70$229,189,216.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016Colin ShannonCEOSell77,019$42.26$3,254,822.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016Linda BaddourCFOSell93,000$42.26$3,930,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016Pra Investors L.P. KkrMajor ShareholderSell4,829,981$42.26$204,114,997.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for PRA Health Sciences (NASDAQ:PRAH)
DateHeadline
07/22/16 08:53 AMEarnings Focus and Crowd Sourced Sentiment Review for PRA Health Sciences, Inc. (NASDAQ:PRAH) - TGP
07/20/16 06:44 PMEquity Roundup: Stock Performance Focus on PRA Health Sciences, Inc. (NASDAQ:PRAH) - Press Telegraph
07/20/16 06:44 PMWere Analysts Bearish PRA Health Sciences Inc (NASDAQ:PRAH) This Week? - Consumer Eagle
07/19/16 07:10 AMPRA Health Sciences, Inc. breached its 50 day moving average in a Bullish Manner : PRAH-US : July 19, 2016 -
07/19/16 04:41 AMPRA Health Sciences, Inc. (NASDAQ:PRAH) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/19/16 04:41 AMShares Lower on the Year PRA Health Sciences, Inc. (NASDAQ:PRAH) - Press Telegraph
07/18/16 06:03 PMResearch details developments in the contract research organizations market global CRO market analysis and forecast to 2020
07/18/16 05:09 PMPRA Health Sciences to Report Second Quarter 2016 Earnings - [GlobeNewswire] - RALEIGH, N.C., July 18, 2016-- PRA Health Sciences, Inc. will release its second quarter 2016 results after the market closes on Thursday, July 28. The Company will also host a conference call on Friday, ...
07/18/16 11:25 AMShare Performance Summary for: PRA Health Sciences, Inc. (NASDAQ:PRAH) - Press Telegraph
07/18/16 11:25 AMStrong Sell Calls For PRA Health Sciences, Inc. (NASDAQ:PRAH) At 0 - Investor Newswire
07/15/16 04:56 PMCrowd Rating and Earnings Recap for PRA Health Sciences, Inc. (NASDAQ:PRAH) - Telanagana Press
07/15/16 04:56 PMOption Market: PRA Health Sciences Inc Risk Hits An Inflection Point - CML News
07/15/16 04:56 PMAnalysts and Technical Snapshot on PRA Health Sciences Inc (NASDAQ:PRAH) - Street Report
07/15/16 11:02 AMConsensus Target and Stock Rating Report: PRA Health Sciences, Inc. (NASDAQ:PRAH) - Telanagana Press
07/14/16 09:32 AMPRA Health Sciences, Inc. (NASDAQ:PRAH) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/13/16 08:52 AMTrading Performance and Target Watch for PRA Health Sciences, Inc. (NASDAQ:PRAH) - Press Telegraph
07/13/16 08:52 AMPRA Health Sciences, Inc. (NASDAQ:PRAH) Updated Price Targets - FTSE News
07/11/16 05:53 PMCompany Stock Focus for PRA Health Sciences, Inc. (NASDAQ:PRAH): Which Way Will Shares Head? - Press Telegraph
07/11/16 05:53 PMHow Analysts Feel About PRA Health Sciences Inc (NASDAQ:PRAH)? - Press Telegraph
07/11/16 10:34 AMStock Performance Rundown on: PRA Health Sciences, Inc. (NASDAQ:PRAH) - Press Telegraph
07/09/16 09:02 AMPRA Health Sciences, Inc. (NASDAQ:PRAH): Tracking Consensus Projections and Analyst Ratings - Telanagana Press
07/07/16 05:57 PMPRA Health Sciences, Inc. (NASDAQ:PRAH) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/07/16 05:57 PMStock Rating Watch and Earnings Insight for PRA Health Sciences, Inc. (NASDAQ:PRAH) - Press Telegraph
07/05/16 10:23 AMPRA Health Sciences, Inc. (NASDAQ:PRAH) Broker Price Targets For The Coming Week - Fiscal Standard
07/03/16 10:05 AMStock Valuation in Review: PRA Health Sciences, Inc. (NASDAQ:PRAH) - Telanagana Press
07/01/16 05:56 PMWhat's Propelling PRA Health Sciences Inc to Decline So Much? - Engelwood Daily
06/30/16 08:46 AMShare Update and Earnings Review for PRA Health Sciences, Inc. (NASDAQ:PRAH) - Press Telegraph
06/30/16 08:46 AMPRA Health Sciences, Inc. (NASDAQ:PRAH) Company Rating and Target Watch - Telanagana Press
06/29/16 05:49 PMFirst Analysis Initiates Coverage on PRA Health Sciences Inc to Equal-weight - Trade Calls
06/28/16 05:49 PMStrong Sell Calls Recommendations For PRA Health Sciences, Inc. (NASDAQ:PRAH) At 0 - Investor Newswire
06/28/16 05:49 PMTop Stock Pick for Quarter: PRA Health Sciences, Inc. (NASDAQ:PRAH) - Engelwood Daily
06/28/16 05:49 PMShares in Decline this Year PRA Health Sciences, Inc. (NASDAQ:PRAH) - Press Telegraph
06/28/16 05:49 PMCredit Suisse Initiates Coverage on PRA Health Sciences Inc to Neutral - Trade Calls
06/27/16 05:53 PMCRO plans Triangle expansion, add 150 workers
06/22/16 05:54 PMCredit Suisse covered (NASDAQ:PRAH) PRA Health Sciences, increasing its stock price target to $43 earlier today
06/22/16 10:38 AMPRA Health Shares Initiated Neutral By Credit Suisse
06/21/16 05:29 PMPRA Health Sciences, Inc. Stock Momentum Hits Weakness - CML News
06/21/16 10:18 AMCredit Suisse Starts PRA Health Sciences (PRAH) at Neutral
06/20/16 07:29 AMStrong Buy Calls Count For PRA Health Sciences, Inc. (NASDAQ:PRAH) At 6 - Investor Newswire
06/20/16 07:29 AMKeyBanc Upgrades PRA Health Sciences Inc to Overweight - TheFounders Daily
06/17/16 05:43 PMPRA Health Sciences Becomes Oversold (PRAH)
06/17/16 08:00 AMPRA Health Sciences (PRAH) Is in Oversold Territory: What's Next? -
06/13/16 05:26 PMKeyBanc Expecting PRA Health Sciences To Beat Estimates, Upgrades To Overweight
06/13/16 01:50 PMPRA Health Sciences, Inc. – Value Analysis (NASDAQ:PRAH) : June 13, 2016 -
06/10/16 06:13 PMTrend Of Rating Given To PRA Health Sciences, Inc. (NASDAQ:PRAH) - Investor Newswire
06/10/16 07:20 AMPRA Health Sciences, Inc. breached its 50 day moving average in a Bearish Manner : PRAH-US : June 10, 2016 -
06/09/16 06:19 PMAnalysts Expect FPX Will Reach $60
06/07/16 06:08 PMPRA Health Sciences, Inc. (NASDAQ:PRAH) Earns Rating Score Of 1.33 - RealistInvestor.com
06/06/16 05:51 PMPRA HEALTH SCIENCES INC. (NASDAQ:PRAH) Financial Condition Compared to S&P 500 - CML News
06/02/16 03:08 PMPRA HEALTH SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -

Social

About PRA Health Sciences

PRA Health Sciences logoPRA Health Sciences, Inc. is a contract research organization (CRO). The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. The Company's integrated services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. The Company's service offerings include Product Registration Services, which includes Phase IIb through III product registration trials and Phase IV trials, inclusive of post-marketing commitments and registries; Strategic Solutions, which provides Embedded Solutions and functional outsourcing services, and Early Development Services, which includes Phase I through Phase IIa clinical trials and bioanalytical laboratory services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PRAH
  • CUSIP:
Key Metrics:
  • Previous Close: $44.22
  • 50 Day Moving Average: $43.65
  • 200 Day Moving Average: $44.09
  • P/E Ratio: 57.21
  • P/E Growth: 1.23
  • Market Cap: $2.68B
  • Beta: 0.48
  • Current Year EPS Consensus Estimate: $2.38 EPS
  • Next Year EPS Consensus Estimate: $2.74 EPS
Additional Links:
PRA Health Sciences (NASDAQ:PRAH) Chart for Saturday, July, 23, 2016